Lv5
880 积分 2021-02-07 加入
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
9天前
已完结
Equecabtagene Autoleucel in Patients With Relapsed or Refractory Multiple Myeloma
9天前
已完结
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
12天前
已完结
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
12天前
已完结
Trends in the development of cellular and gene therapy in China
1个月前
已完结
Bayesian dose escalation with overdose and underdose control utilizing all toxicities in Phase I/II clinical trials
1个月前
已完结
The Efficacy and Safety of Ramucirumab in Heavily Pretreated Advanced Hepatocellular Carcinoma
1个月前
已完结
Sequencing Systemic Therapy in Hepatocellular Carcinoma
1个月前
已完结
Challenges and Lessons Learned in Autologous Chimeric Antigen Receptor T-Cell Therapy Development from a Statistical Perspective
2个月前
已完结
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
3个月前
已完结
皖公网安备34019202002308
